Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy
Shengli Dong(Zhejiang Medicine (China)), Suresh K. Alahari(Louisiana State University Health Sciences Center New Orleans)
Cited by 8
Related Papers
Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment
|International Journal of Cancer|2019|17
Case report: Type I diastematomyelia with breast abnormalities and clubfoot
|Frontiers in Surgery|2022|6